Mufg Americas Holdings Corp Vertex Pharmaceuticals Inc Transaction History

Mufg Americas Holdings Corp

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	SELL	$273.83 - $305.53 $85,161 - $95,019	-311 Reduced 86.15%	50 $14,000
Q3 2022 Oct 31, 2022	SELL	$273.83 - $305.53 $85,161 - $95,019	-311 Reduced 86.15%	50 $14,000
Q1 2022 Dec 01, 2022	SELL	$221.42 - $260.97 $13,063 - $15,397	-59 Reduced 14.05%	361 $95,000
Q1 2022 May 06, 2022	SELL	$221.42 - $260.97 $13,063 - $15,397	-59 Reduced 14.05%	361 $95,000
Q3 2021 Dec 01, 2022	BUY	$181.39 - $202.99 $11,790 - $13,194	65 Added 18.31%	420 $77,000
Q3 2021 Nov 05, 2021	BUY	$181.39 - $202.99 $11,790 - $13,194	65 Added 18.31%	420 $77,000
Q1 2021 Dec 01, 2022	SELL	$207.02 - $241.31 $1,656 - $1,930	-8 Reduced 2.2%	355 $76,000
Q1 2021 Apr 30, 2021	SELL	$207.02 - $241.31 $1,656 - $1,930	-8 Reduced 2.2%	355 $76,000
Q4 2020 Dec 01, 2022	BUY	$207.01 - $276.09 $1,656 - $2,208	8 Added 2.25%	363 $86,000
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $1,656 - $2,208	8 Added 2.25%	363 $86,000
Q2 2020 Dec 01, 2022	BUY	$225.48 - $295.8 $68,771 - $90,219	305 Added 610.0%	355 $103,000
Q2 2020 Aug 06, 2020	SELL	$225.48 - $295.8 $4,509 - $5,916	-20 Reduced 5.33%	355 $103,000
Q2 2019 Aug 09, 2019	SELL	$164.61 - $190.37 $4,115 - $4,759	-25 Reduced 6.25%	375 $69,000
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $49,446 - $58,799	302 Added 308.16%	400 $74,000
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $4,253 - $5,381	28 Added 40.0%	98 $16,000
Q2 2017 Aug 07, 2017	BUY	N/A	70	70 $0

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

Stay updated on Mufg Americas Holdings Corp with notifications on news.